Diabetes, Bone and Glucose-Lowering Agents: Basic Biology

Diabetologia - Germany
doi 10.1007/s00125-017-4269-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Effects of Intensive Glucose Lowering in Type 2 Diabetes

Yearbook of Endocrinology
2009English

Blood Glucose-Lowering Therapy in Adults With Type 2 Diabetes

Nurse Prescribing
2016English

Glucose-Lowering Medication Selection in Patients With Diabetes and Acute Cerebrovascular Accident

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2020English

Trend of Cost of Newer Glucose-Lowering Agents in Patients With Type 2 Diabetes Mellitus: Evidence From a Medical System in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes: Reconciling the Recent Clinical Trial Data

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Glucose-Lowering Mechanism of Clofibrate and Its Long-Term Effect on Glucose Tolerance in Non-Insulin Dependent Diabetes Mellitus

The Journal of Japan Atherosclerosis Society
1984English

Impact of Cancer on Adherence to Glucose-Lowering Drug Treatment in Individuals With Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Distinct Glucose Lowering and Beta Cell Protective Effects of Vanadium and Food Restriction in Streptozotocin-Diabetes

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1999English

Introduction: Basic Biology

Nihon Kessho Gakkaishi
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy